Respiratory Flashcards
Large bud development, trachea and bronchi differation
Embryonic Stage of lung development (week 1-5)
formation of conducting airways, terminal bronchioles, immature neural network, appearane of type-II pneumocytes
pseudoglandular stage of lung development (week 6-16)
lung periphery formation, increased vacularization, appearance of type-I pneymocytes, formation of air-blood interface
canalicular stage of lung dev week 17-27
alveolar saccules formation, surfactant detectable in amino fluid, ECM formation
Saccular stage of lung dev week 27-36
mature alveolar formation, proliferation and expansion of capillaries, nerve and gas exchange areas
alveolar stage of lung dev week 36 weeks - 7-10 years of life
Surfactant is produced by which cells and when
Type-II pneymocytes; 25-30 weeks and continue to term
Phosphatidylglycerol (PG) has a correlation with which disease process
RDS
when PG is present there is less than 1% chance of baby developing RDS
it is either absent or present in amniotic fluid
Lectithin/sphingomyelin (L/S) ratio is used to access what
fetal lung maturity
L/S ratio greater than ____ is considered to indicate fetal lung maturity
2:1
An infant born to a _____ mother may still develop RDS even with a mature L/S ratio
Diabetic mother
Chronic fetal stress (i.e maternal hypertension, maternal drug use, smoking, bleeding, etc) will tend to do what to a fetus’ lungs ?
mature quicker - accelerates surfactant production resulting in a mature L/S ratio in premies
Betamethasone and dexamethasone are given to whom and for what
to mothers who are expected to deliver between 24-34 weeks of gestation soon
Definition - Increasing resp difficulty in the first 3-6 hours post birth, leading to hypoxia and hypoventilation
with possible progressive atelectasis
Definition of RDS
Pathophysio and etiology - surfactant deficiency leading to diffuse alveolar atelectasis, pulm edema, and cell injury leading to the leaking of serum proteins that inhibit surfactant function into the alveoli
RDS
Clinical presentation of _____ (early)
tachypnea, audible expiratory grunting, retractions, nasal flaring, cyanosis, increased O2 requirements
RDS
Diagnostic studies/labwork for RDS
Xray, blood gas, blood cultures/CBC/GBS testing is risk factors for infection present, and glucose
Management of RDS
supportive until disease resolves (is self-limiting/transient) and to prevent further lung injury
give surfactant
Prophylaxis treatment of surfactant therapy includes
1 dose given within the first 15 mins of life for infants less than 27-30 weeks especially if mother did not have prenatal steroids
Early rescue treatment of surfactant therapy includes
1-2 hours of life with signs of RDS
multi doses can be given
the goal of therapy being to avoid progressive alveolar atelectasis leading to resp failure requiring PPV
Late rescue treatment of surfactant therapy includes
4-6 hours of life for infants requiring mechanical ventilation and more than 40% O2
INSURE means
intubation and surf administration with immediate extubation to nasal CPAP
TTN
delay in the removal of lung fluid
What initiates the removal of lung fluid
labor initiates the sodium chloride channels within the lungs to absorb the fluid
Duration of TTN
1-5 days
S/S of TTN
Tachypnea grunting retractions nasal flaring resp acidosis
Perihilar haziness
hyperinflation & streakiness
Treatment of TTN
adequate fluid intake
maintain ABGS
supplemental oxygen and or CPAP
antibiotics always if theres prenatal hx indicating
Meconium definition
consists of cells and bile salts that are found in the intestinal tract of the fetus
MAS
Meconium aspirated by the fetus d/t stress or repeated episodes of asphyxia in utero
Ball Valve phenomena
partial obstruction that allows gas in but not out
= uneven ventilation d/t lung collapse / air trapping
which then leads to hyperventilation
S/S of MAS
Tachypnea grunting retractions stained green nail beds barrel shaped chest coarse crackles resp/meta acidosis low PaO2 CXR - diffuse coarse increase in lung markings and hyperinflation
Treatment MAS
NRP in delivery room frequent ABGs assisted ventilation (HFV) iNo if PPHN Surfactant therapy
MAS complications
air leaks (pneumomediastinum) pphn chemical pneumonitis acidosis hypoglycemia neuro effects d/t possible asphyxia
PPHN
Persistant higher pulmonary vascular resistance than the systemic resistance
diagnosed after transition from interuterine to extrauterine life
(within first 72 hrs of life)
3 types of causes of PPHN
underdevelopement
maladaption
maldevelopment
Causes of PPHN underdevelopment type
- pulmonary hypoplasia
- lesions or masses in the lung (Diaphragmetic hernia - lungs didnt have the space to grow)
- congenital heart dx
Maladaption PPHN causes
- hypoxia/asphyxia/perinatal stress (most common)
- pulm dx (RDS, MAS, pneumonia)
- hemorrhage
- bacterial sepsis
- prenatal pulm hypertension
- complications at delivery (CNS, resus, hypothermia)
- acidosis
- polycthemia
Maldevelopment PPHN causes
- intrauterine asphyxia (blood to fetus lung)
- fetal ductal closure
- congenital heart dx
- can be unknown
S/S PPHN (10)
tachypnea retractions cyanosis low PaCo2 Low BP murmur hypoglycemia hypocalcemia meta acidosis decreased urine output
Dx PPHN
CXR - may be normal unless other dx process ongoing pre/post ductal Pao2 hyperoxia test Echo abg = acidosis/hypoxemia CBC and BMP
Tx of PPHN
correct ABG minimal handling to reduce stress umbilical artery/venous catheter pre/post ductal sats monitoring vasopressors pulmonary vasodilators (sildenafil) ventilation/oxygen iNO surfactant ECMO
2 types of Pneumonia
congenital and neonatal